A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

about

Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitness

P2860

Q40640181-2E5550F1-D584-4027-AD5B-43DE0173EE69

P2860

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

Item

http://www.wikidata.org/entity/Q36248077

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@ast

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@en

type

Item

label

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@ast

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@en

prefLabel

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@ast

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@en

P1476

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

@en

P2093

Catherine M Crosby

http://www.w3.org/2001/XMLSchema#string

Eric A Weaver

http://www.w3.org/2001/XMLSchema#string

Michael A Barry

http://www.w3.org/2001/XMLSchema#string

Reeti Khare

http://www.w3.org/2001/XMLSchema#string

P2860

Codon usage limitation in the expression of HIV-1 envelope glycoprotein

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

Genetic live vaccines mimic the antigenicity but not pathogenicity of live viruses.

HIV-1 vaccine development after STEP.

Contribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in mice

In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment.

A model for testing the immunogenicity of simian immunodeficiency virus and simian-human immunodeficiency virus vaccine candidates in mice.

Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.

Mass spectrometry approach and ELISA reveal the effect of codon optimization on N-linked glycosylation of HIV-1 gp120

Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys

P304

47-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VIREP.2015.03.002

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273579920

http://www.w3.org/2001/XMLSchema#string

P698

26550557

http://www.w3.org/2001/XMLSchema#string

P932

4632983

http://www.w3.org/2001/XMLSchema#string

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

about

P2860

P2860

A Novel Codon-optimized SIV Gag-pol Immunogen for Gene-based Vaccination

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932